C.M. Lanier
Papers
1
Total Citations
22
H-Index
1
About
C.M. Lanier is a leading clinical researcher in head and neck oncology, with a focused expertise in the treatment of human papillomavirus-associated oropharyngeal squamous cell carcinoma. Their most cited work, a 2023 study comparing primary transoral robotic surgery (TORS) versus radiotherapy (RT), represents a pivotal contribution to the field. This investigation, which has garnered 22 citations, directly addresses the critical clinical question of how to optimize survival outcomes—including progression-free and overall survival—while preserving essential swallowing function in early-stage patients. By rigorously comparing these two modern treatment modalities, Lanier’s research provides evidence-based guidance that helps clinicians and patients navigate the trade-offs between surgical and non-surgical approaches. This work has significant implications for de-escalation strategies and quality of life in HPV-positive disease. Lanier’s scholarship is characterized by a commitment to functional preservation and patient-centered outcomes, making their findings highly influential among surgeons, radiation oncologists, and oncologists seeking to refine treatment paradigms for this growing patient population.
Research Focus
Key Achievements
Top Papers
- 1